AZELAIC ACID

AZELAIC ACID was reported 988 times

AZELAIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIAMINE OXIDASE DEFICIENCY 1 0.2500
1 PATHOLOGICAL TOOTH FRACTURE 1 0.1250
2 CARBOHYDRATE TOLERANCE DECREASED 1 0.0455
3 HYPOCHOLESTEROLAEMIA 13 0.0368
4 APPLICATION SITE PALLOR 1 0.0303
5 SKIN LESION INFLAMMATION 4 0.0303
6 OSTEOMA CUTIS 1 0.0294
7 LACK OF INFUSION SITE ROTATION 1 0.0208
8 PACEMAKER GENERATED RHYTHM 1 0.0189
9 LUPUS VULGARIS 22 0.0175
10 COMPLICATED FRACTURE 1 0.0161
11 BLEPHAROSPASM 95 0.0151
12 ACQUIRED PORPHYRIA 1 0.0141
13 HEPATIC ENZYME 2 0.0134
14 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 7 0.0125
15 DIASTASIS RECTI ABDOMINIS 2 0.0124
16 CHORIORETINAL SCAR 1 0.0120
17 SWOLLEN JOINT COUNT 3 0.0120
18 OVERLAP SYNDROME 8 0.0114
19 MIXED INCONTINENCE 1 0.0110
20 PELVIC ORGAN PROLAPSE 1 0.0110
21 POSTOPERATIVE HERNIA 1 0.0109
22 RHEUMATIC FEVER 48 0.0108
23 FACET JOINT SYNDROME 35 0.0107
24 ADMINISTRATION SITE DISCOMFORT 2 0.0106
25 CARDIAC VALVE RUPTURE 1 0.0098
26 SWOLLEN JOINT COUNT INCREASED 31 0.0097
27 CAROTID ARTERY ATHEROMA 1 0.0094
28 PERIPHERAL VENOUS DISEASE 38 0.0093
29 RETINITIS 16 0.0093
30 DISLOCATION OF VERTEBRA 21 0.0092
31 ELECTROCONVULSIVE THERAPY 1 0.0092
32 X-RAY ABNORMAL 16 0.0089
33 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 18 0.0087
34 C-REACTIVE PROTEIN 8 0.0086
35 DEEP VEIN THROMBOSIS POSTOPERATIVE 17 0.0085
36 IRON METABOLISM DISORDER 1 0.0084
37 BLEPHAROPLASTY 1 0.0082
38 ONYCHOMADESIS 28 0.0067
39 MALABSORPTION FROM APPLICATION SITE 1 0.0065
40 ROSACEA 29 0.0062
41 LUMBOSACRAL RADICULOPATHY 1 0.0062
42 INFANTILE HAEMANGIOMA 1 0.0062
43 INFUSION SITE REACTION 18 0.0060
44 DOSING ERROR 1 0.0060
45 LABELLED DRUG-FOOD INTERACTION ISSUE 1 0.0059
46 PRODUCT PHYSICAL CONSISTENCY ISSUE 32 0.0058
47 BREAST CANCER STAGE III 37 0.0057
48 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 40 0.0056
49 BALLISMUS 1 0.0051
50 OCULAR ROSACEA 1 0.0049
51 PORPHYRIA ACUTE 7 0.0049
52 RHEUMATOID FACTOR POSITIVE 28 0.0048
53 DUODENAL ULCER PERFORATION 36 0.0048
54 PIERRE ROBIN SYNDROME 1 0.0047
55 CHOLELITHOTOMY 1 0.0046
56 TASTE DISORDER 93 0.0046
57 FOLLICULITIS 45 0.0043
58 MECHANICAL URTICARIA 2 0.0043
59 PERIPHERAL VEIN THROMBOSIS 1 0.0042
60 LIVE BIRTH 35 0.0042
61 KYPHOSCOLIOSIS 1 0.0038
62 PALMOPLANTAR PUSTULOSIS 2 0.0038
63 CLINODACTYLY 1 0.0036
64 CHOLESTEATOMA 1 0.0036
65 ORTHOSIS USER 1 0.0036
66 CARBUNCLE 1 0.0035
67 SERONEGATIVE ARTHRITIS 4 0.0035
68 BONE EROSION 12 0.0034
69 ADENOMYOSIS 2 0.0034
70 MONARTHRITIS 1 0.0033
71 BACK INJURY 36 0.0033
72 WOUND INFECTION 36 0.0033
73 OPEN ANGLE GLAUCOMA 2 0.0033
74 FEEDING TUBE COMPLICATION 1 0.0032
75 BURSITIS 39 0.0032
76 CONDUCTIVE DEAFNESS 1 0.0031
77 CELLULITE 1 0.0031
78 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
79 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 2 0.0030
80 SYNOVITIS 54 0.0030
81 LARYNGOMALACIA 1 0.0030
82 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
83 EXOSTOSIS 27 0.0030
84 EPILEPSY 90 0.0029
85 INGROWN HAIR 2 0.0029
86 MULTIPLE SYSTEM ATROPHY 1 0.0028
87 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
88 MUSCLE INJURY 23 0.0028
89 GLOBULINS INCREASED 1 0.0027
90 FEEDING TUBE USER 1 0.0027
91 VITAMIN B COMPLEX DEFICIENCY 2 0.0027
92 HYPERCHOLESTEROLAEMIA 26 0.0027
93 CHOLANGITIS ACUTE 2 0.0026
94 C-REACTIVE PROTEIN ABNORMAL 17 0.0026
95 LIP DRY 24 0.0026
96 PEMPHIGUS 33 0.0026
97 PERICARDITIS 44 0.0026
98 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
99 PREGNANCY TEST POSITIVE 1 0.0025
100 DRUG TOLERANCE DECREASED 7 0.0025
101 MITRAL VALVE PROLAPSE 4 0.0024
102 HELICOBACTER INFECTION 24 0.0023
103 APPLICATION SITE PARAESTHESIA 3 0.0023
104 JOINT RANGE OF MOTION DECREASED 30 0.0022
105 PERINEAL ABSCESS 1 0.0022
106 ALLERGY TO ARTHROPOD STING 1 0.0022
107 INJURY ASPHYXIATION 1 0.0022
108 BIOPSY BONE MARROW 1 0.0021
109 MENINGISM 1 0.0021
110 BLOOD CREATINE ABNORMAL 1 0.0021
111 TELANGIECTASIA 2 0.0021
112 PUSTULAR PSORIASIS 7 0.0020
113 DERMATITIS INFECTED 1 0.0020
114 HYPERMOBILITY SYNDROME 1 0.0020
115 NAIL DISORDER 17 0.0019
116 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
117 PHARYNGEAL MASS 1 0.0019
118 COATING IN MOUTH 1 0.0019
119 HAND DEFORMITY 24 0.0018
120 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
121 ONYCHOMYCOSIS 8 0.0018
122 MILK ALLERGY 1 0.0018
123 PERIRECTAL ABSCESS 2 0.0018
124 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
125 JUGULAR VEIN DISTENSION 1 0.0018
126 GALLBLADDER NON-FUNCTIONING 1 0.0018
127 ACUTE SINUSITIS 3 0.0017
128 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
129 LUMBAR RADICULOPATHY 2 0.0017
130 IRREGULAR BREATHING 1 0.0017
131 GRIP STRENGTH DECREASED 15 0.0017
132 BREAST CANCER STAGE II 14 0.0017
133 MALE SEXUAL DYSFUNCTION 1 0.0017
134 RASH VESICULAR 8 0.0017
135 ALLERGY TO METALS 1 0.0016
136 WOUND 46 0.0016
137 CUTANEOUS VASCULITIS 6 0.0016
138 XEROSIS 2 0.0016
139 DERMATOSIS 1 0.0016
140 PLEURAL DISORDER 1 0.0016
141 BAND SENSATION 2 0.0016
142 PERIORAL DERMATITIS 1 0.0016
143 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
144 BLADDER IRRITATION 1 0.0016
145 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
146 LUPUS-LIKE SYNDROME 14 0.0015
147 IRRITABLE BOWEL SYNDROME 33 0.0015
148 MAMMOGRAM ABNORMAL 1 0.0015
149 EYELID PAIN 3 0.0015
150 NORMAL NEWBORN 8 0.0015
151 CALCULUS BLADDER 2 0.0015
152 CONGENITAL HAND MALFORMATION 1 0.0015
153 HEAD TITUBATION 2 0.0015
154 ARACHNOIDITIS 1 0.0014
155 FIBROMYALGIA 35 0.0014
156 GLOSSODYNIA 32 0.0014
157 CONGENITAL HYDRONEPHROSIS 1 0.0014
158 CERVIX DISORDER 1 0.0014
159 AMNIOTIC CAVITY INFECTION 1 0.0014
160 GRAFT LOSS 1 0.0014
161 RECALLED PRODUCT ADMINISTERED 13 0.0014
162 POOR QUALITY PRODUCT ADMINISTERED 14 0.0013
163 ACNE CYSTIC 4 0.0013
164 CHROMATOPSIA 1 0.0013
165 EYE INJURY 4 0.0013
166 NIGHT SWEATS 42 0.0013
167 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 3 0.0013
168 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
169 JOINT DESTRUCTION 2 0.0013
170 INTRACRANIAL PRESSURE INCREASED 7 0.0013
171 BREAST CALCIFICATIONS 1 0.0013
172 LIP ERYTHEMA 1 0.0013
173 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 8 0.0012
174 GENITAL INFECTION FUNGAL 1 0.0012
175 GIANT CELL ARTERITIS 1 0.0012
176 MEDICAL PROCEDURE 2 0.0012
177 OBESITY 19 0.0012
178 ULCER HAEMORRHAGE 8 0.0012
179 CERVICAL SPINAL STENOSIS 2 0.0012
180 ENDOCRINE OPHTHALMOPATHY 1 0.0012
181 INFUSION SITE DISCOLOURATION 1 0.0011
182 AUTOIMMUNE DISORDER 11 0.0011
183 PAPILLOEDEMA 5 0.0011
184 SPONDYLITIS 4 0.0011
185 C-REACTIVE PROTEIN INCREASED 40 0.0011
186 MIGRAINE 104 0.0011
187 APPLICATION SITE DERMATITIS 1 0.0011
188 IMPAIRED HEALING 35 0.0011
189 SACROILIITIS 2 0.0011
190 SUBCUTANEOUS ABSCESS 5 0.0010
191 INFUSION SITE NODULE 1 0.0010
192 HYPERTONIC BLADDER 3 0.0010
193 FINGER DEFORMITY 5 0.0010
194 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
195 GALLBLADDER INJURY 2 0.0010
196 GAIT INABILITY 33 0.0010
197 SPINAL FUSION SURGERY 4 0.0010
198 PSORIATIC ARTHROPATHY 40 0.0010
199 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
200 INFUSION SITE DISCOMFORT 1 0.0010
201 EYELIDS PRURITUS 3 0.0010
202 TYPE 2 DIABETES MELLITUS 32 0.0009
203 DRUG INTOLERANCE 91 0.0009
204 PRESCRIBED OVERDOSE 18 0.0009
205 SYSTEMIC LUPUS ERYTHEMATOSUS 33 0.0009
206 INFUSION SITE MASS 1 0.0009
207 PILOERECTION 1 0.0009
208 AORTIC DILATATION 1 0.0009
209 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
210 CATHETER SITE DISCHARGE 1 0.0009
211 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
212 EAR PAIN 17 0.0009
213 OSTEOARTHRITIS 37 0.0009
214 TACHYPHRENIA 3 0.0009
215 POLYDACTYLY 1 0.0009
216 INFUSION SITE INFECTION 2 0.0009
217 BLOOD CHOLESTEROL INCREASED 40 0.0009
218 PRESCRIBED UNDERDOSE 17 0.0009
219 HEPATIC CIRRHOSIS 16 0.0009
220 GROIN ABSCESS 1 0.0008
221 STOMATITIS 51 0.0008
222 RESPIRATORY DISORDER 25 0.0008
223 INFLAMMATION 43 0.0008
224 BRONCHIAL HYPERREACTIVITY 1 0.0008
225 INFUSION SITE WARMTH 1 0.0008
226 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
227 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0008
228 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
229 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
230 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
231 BLISTER 44 0.0008
232 SLEEP DISORDER 55 0.0008
233 EPIGASTRIC DISCOMFORT 3 0.0008
234 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
235 WALKING AID USER 5 0.0008
236 ACROCHORDON 1 0.0008
237 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
238 SCIATICA 12 0.0008
239 LIP EXFOLIATION 1 0.0008
240 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
241 LIP BLISTER 2 0.0007
242 LIVER INJURY 18 0.0007
243 LOWER LIMB FRACTURE 14 0.0007
244 MEMORY IMPAIRMENT 100 0.0007
245 NASAL DISCHARGE DISCOLOURATION 1 0.0007
246 INCISIONAL HERNIA 1 0.0007
247 CHRONIC FATIGUE SYNDROME 1 0.0007
248 HALLUCINATIONS, MIXED 3 0.0007
249 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
250 CONNECTIVE TISSUE DISORDER 1 0.0007
251 PRODUCT CONTAINER ISSUE 6 0.0007
252 HAEMORRHAGE IN PREGNANCY 1 0.0007
253 EYELID MARGIN CRUSTING 2 0.0007
254 CHAPPED LIPS 3 0.0007
255 DYSPNOEA AT REST 2 0.0007
256 PRODUCT LABEL CONFUSION 4 0.0007
257 APPLICATION SITE PAIN 15 0.0007
258 INFUSION SITE INDURATION 1 0.0007
259 GENERAL SYMPTOM 5 0.0007
260 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
261 HYPOAESTHESIA 99 0.0007
262 MYOCLONIC EPILEPSY 1 0.0007
263 AGE-RELATED MACULAR DEGENERATION 1 0.0007
264 DERMATITIS ACNEIFORM 4 0.0007
265 PARAESTHESIA 103 0.0007
266 LIVER FUNCTION TEST INCREASED 14 0.0007
267 PORTAL HYPERTENSION 2 0.0006
268 POLYCYSTIC OVARIES 1 0.0006
269 BACTERIAL VAGINOSIS 1 0.0006
270 GESTATIONAL DIABETES 3 0.0006
271 FREQUENT BOWEL MOVEMENTS 17 0.0006
272 PULMONARY FIBROSIS 12 0.0006
273 DRY MOUTH 50 0.0006
274 COSTOCHONDRITIS 1 0.0006
275 ARTHROPATHY 34 0.0006
276 APPLICATION SITE BURN 3 0.0006
277 INFUSION SITE HAEMORRHAGE 2 0.0006
278 WHEEZING 36 0.0006
279 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
280 DRUG TOLERANCE 3 0.0006
281 BILIARY DYSKINESIA 1 0.0006
282 LUNG DISORDER 28 0.0006
283 MACULOPATHY 2 0.0006
284 FEAR OF DISEASE 1 0.0006
285 SKIN WEEPING 2 0.0006
286 MYOSITIS 5 0.0006
287 APPLICATION SITE DISCOMFORT 1 0.0006
288 PRODUCT RESIDUE PRESENT 3 0.0006
289 DEVICE ALARM ISSUE 1 0.0006
290 ABDOMINAL PAIN UPPER 113 0.0005
291 FOOT DEFORMITY 6 0.0005
292 NECK PAIN 30 0.0005
293 NASAL OBSTRUCTION 1 0.0005
294 PERIORBITAL SWELLING 3 0.0005
295 LIP DISORDER 1 0.0005
296 SWELLING 49 0.0005
297 HEPATIC MASS 1 0.0005
298 CONGENITAL ANOMALY 4 0.0005
299 EARLY SATIETY 1 0.0005
300 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
301 INFLAMMATORY BOWEL DISEASE 5 0.0005
302 OCCULT BLOOD POSITIVE 1 0.0005
303 TREATMENT FAILURE 42 0.0005
304 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
305 ANORECTAL DISORDER 1 0.0005
306 HEPATIC ENZYME INCREASED 34 0.0005
307 MUSCULOSKELETAL PAIN 26 0.0005
308 JOINT STIFFNESS 13 0.0005
309 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
310 DELIRIUM 17 0.0005
311 INFUSION RELATED REACTION 32 0.0005
312 HYPOSPADIAS 1 0.0005
313 LIVEDO RETICULARIS 1 0.0005
314 RHEUMATOID ARTHRITIS 54 0.0005
315 JOINT DISLOCATION 5 0.0005
316 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
317 INJURY 33 0.0005
318 ABSCESS LIMB 2 0.0005
319 SHOULDER OPERATION 2 0.0005
320 CATHETER SITE ERYTHEMA 1 0.0005
321 SKIN HYPERPIGMENTATION 4 0.0005
322 DEREALISATION 1 0.0005
323 BLOOD MAGNESIUM DECREASED 4 0.0005
324 OSTEOPOROSIS 19 0.0005
325 HYSTERECTOMY 4 0.0005
326 GASTRIC BYPASS 1 0.0005
327 SKIN IRRITATION 21 0.0005
328 CERVICAL DYSPLASIA 1 0.0005
329 INSURANCE ISSUE 7 0.0005
330 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
331 ENDOMETRIAL CANCER 1 0.0005
332 MIDDLE EAR EFFUSION 1 0.0005
333 FACIAL PAIN 4 0.0004
334 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
335 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
336 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
337 BRAIN OPERATION 1 0.0004
338 APHTHOUS STOMATITIS 1 0.0004
339 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
340 PRODUCT USE IN UNAPPROVED INDICATION 107 0.0004
341 AUTOIMMUNE HEPATITIS 3 0.0004
342 SWELLING FACE 28 0.0004
343 DYSMORPHISM 1 0.0004
344 SKIN ABRASION 2 0.0004
345 HAEMATOLOGICAL INFECTION 1 0.0004
346 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
347 COELIAC DISEASE 4 0.0004
348 SENSITIVE SKIN 3 0.0004
349 GENERAL PHYSICAL HEALTH DETERIORATION 47 0.0004
350 GASTROINTESTINAL TUBE INSERTION 1 0.0004
351 PRODUCT QUALITY ISSUE 54 0.0004
352 CHEMICAL BURN OF SKIN 1 0.0004
353 ENDODONTIC PROCEDURE 1 0.0004
354 DISCOMFORT 24 0.0004
355 ABNORMAL UTERINE BLEEDING 1 0.0004
356 MENOPAUSE 1 0.0004
357 CONCUSSION 3 0.0004
358 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
359 CATHETER SITE PAIN 1 0.0004
360 BASAL CELL CARCINOMA 6 0.0004
361 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
362 ANAESTHETIC COMPLICATION 1 0.0004
363 GASTROINTESTINAL INJURY 1 0.0004
364 BLOOD SODIUM INCREASED 1 0.0004
365 CHEILITIS 2 0.0004
366 CHONDROPATHY 1 0.0004
367 PRODUCT PRESCRIBING ISSUE 8 0.0004
368 ASPIRATION 4 0.0004
369 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
370 PLEURITIC PAIN 1 0.0004
371 HEART RATE ABNORMAL 2 0.0004
372 PRODUCT LEAKAGE 2 0.0004
373 ACNE 27 0.0004
374 UTERINE PERFORATION 3 0.0004
375 OESOPHAGEAL STENOSIS 1 0.0004
376 ESCHERICHIA SEPSIS 1 0.0003
377 SKIN WARM 2 0.0003
378 BILIARY COLIC 1 0.0003
379 LUMBAR SPINAL STENOSIS 1 0.0003
380 SPINAL OSTEOARTHRITIS 3 0.0003
381 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
382 EXPOSURE DURING PREGNANCY 21 0.0003
383 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
384 SINUS HEADACHE 2 0.0003
385 ADRENAL INSUFFICIENCY 4 0.0003
386 HIP ARTHROPLASTY 5 0.0003
387 PIGMENTATION DISORDER 2 0.0003
388 SKIN BURNING SENSATION 23 0.0003
389 PRE-EXISTING CONDITION IMPROVED 2 0.0003
390 NASAL DRYNESS 2 0.0003
391 SWELLING OF EYELID 2 0.0003
392 INFUSION SITE PRURITUS 1 0.0003
393 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
394 BLADDER PAIN 1 0.0003
395 POLYMYALGIA RHEUMATICA 1 0.0003
396 ILL-DEFINED DISORDER 19 0.0003
397 GASTROINTESTINAL DISORDER 28 0.0003
398 THERAPY NON-RESPONDER 14 0.0003
399 FEELING HOT 19 0.0003
400 PRODUCT USE ISSUE 58 0.0003
401 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
402 BACK DISORDER 5 0.0003
403 AMNESIA 20 0.0003
404 JOINT SWELLING 37 0.0003
405 LYMPHOCYTE COUNT INCREASED 1 0.0003
406 APPLICATION SITE ERYTHEMA 8 0.0003
407 SOMNAMBULISM 2 0.0003
408 URTICARIA 51 0.0003
409 DEAFNESS NEUROSENSORY 1 0.0003
410 OTITIS MEDIA 1 0.0003
411 EXPOSURE DURING BREAST FEEDING 1 0.0003
412 PEPTIC ULCER 1 0.0003
413 CHOLECYSTITIS CHRONIC 2 0.0003
414 APPLICATION SITE DRYNESS 1 0.0003
415 MOBILITY DECREASED 21 0.0003
416 PERIPHERAL SWELLING 45 0.0003
417 CROHN'S DISEASE 2 0.0003
418 ECCHYMOSIS 2 0.0003
419 HYPERTRANSAMINASAEMIA 2 0.0003
420 CAROTID ARTERY STENOSIS 1 0.0003
421 HANGOVER 1 0.0003
422 NECROTISING FASCIITIS 1 0.0003
423 HEART DISEASE CONGENITAL 1 0.0003
424 THERMAL BURN 2 0.0003
425 MUSCULAR WEAKNESS 32 0.0003
426 CONTUSION 27 0.0003
427 ABDOMINAL DISCOMFORT 47 0.0003
428 OEDEMA 15 0.0003
429 RASH PUSTULAR 2 0.0003
430 INTENTIONAL UNDERDOSE 2 0.0003
431 FOOD INTOLERANCE 1 0.0003
432 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
433 ARTHROPOD BITE 2 0.0003
434 COLITIS ULCERATIVE 12 0.0003
435 OCULAR DISCOMFORT 3 0.0003
436 CHRONIC SINUSITIS 1 0.0003
437 CONFUSIONAL STATE 43 0.0003
438 APHASIA 8 0.0003
439 AUTOIMMUNE THYROIDITIS 1 0.0003
440 DERMATITIS CONTACT 3 0.0003
441 ROAD TRAFFIC ACCIDENT 11 0.0003
442 PROCEDURAL COMPLICATION 2 0.0003
443 FOOD ALLERGY 2 0.0003
444 PANIC DISORDER 1 0.0003
445 APHTHOUS ULCER 2 0.0003
446 ORAL HERPES 5 0.0003
447 SPLENOMEGALY 3 0.0003
448 ADVERSE DRUG REACTION 23 0.0003
449 DRUG-INDUCED LIVER INJURY 8 0.0003
450 DEPRESSION 58 0.0003
451 DRY SKIN 34 0.0003
452 DISABILITY 5 0.0003
453 CHOLECYSTITIS 3 0.0003
454 RASH 109 0.0002
455 BLEPHARITIS 1 0.0002
456 ORGAN FAILURE 1 0.0002
457 ENURESIS 1 0.0002
458 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
459 WEIGHT INCREASED 55 0.0002
460 BURNING SENSATION 17 0.0002
461 GENERALISED OEDEMA 3 0.0002
462 MENSTRUAL DISORDER 2 0.0002
463 VOMITING 113 0.0002
464 NEPHROLITHIASIS 11 0.0002
465 KNEE ARTHROPLASTY 5 0.0002
466 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
467 INFUSION SITE ERYTHEMA 2 0.0002
468 LABORATORY TEST ABNORMAL 7 0.0002
469 SKIN PLAQUE 2 0.0002
470 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
471 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
472 INTERVERTEBRAL DISC DISORDER 1 0.0002
473 HEPATIC PAIN 1 0.0002
474 VITAMIN D DECREASED 2 0.0002
475 SCAR 4 0.0002
476 INFUSION SITE PAIN 3 0.0002
477 PAIN 142 0.0002
478 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
479 ASTHMA 26 0.0002
480 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
481 MELANOCYTIC NAEVUS 1 0.0002
482 BLOOD CALCIUM INCREASED 2 0.0002
483 ORAL CANDIDIASIS 3 0.0002
484 LIGAMENT RUPTURE 1 0.0002
485 ADVERSE REACTION 3 0.0002
486 LIVER DISORDER 10 0.0002
487 EAR INFECTION 6 0.0002
488 SINUSITIS 23 0.0002
489 MALIGNANT MELANOMA 3 0.0002
490 GASTROINTESTINAL INFECTION 2 0.0002
491 SINUS CONGESTION 3 0.0002
492 DRY EYE 11 0.0002
493 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
494 HIDRADENITIS 2 0.0002
495 HAEMOGLOBIN INCREASED 1 0.0002
496 SKIN LESION 6 0.0002
497 INJECTION SITE PAPULE 1 0.0002
498 LUMBAR VERTEBRAL FRACTURE 1 0.0002
499 EYE OPERATION 1 0.0002
500 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
501 MEDICATION ERROR 12 0.0002
502 SEASONAL ALLERGY 3 0.0002
503 PRE-ECLAMPSIA 1 0.0002
504 LIP SWELLING 7 0.0002
505 ENDOMETRIOSIS 1 0.0002
506 RECTAL HAEMORRHAGE 9 0.0002
507 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
508 ALOPECIA 41 0.0002
509 IMPAIRED QUALITY OF LIFE 3 0.0002
510 DERMATITIS ATOPIC 11 0.0002
511 LIMB OPERATION 1 0.0002
512 GUILLAIN-BARRE SYNDROME 1 0.0002
513 ADVERSE EVENT 19 0.0002
514 SKIN FISSURES 4 0.0002
515 THERAPY CHANGE 2 0.0002
516 DYSPEPSIA 20 0.0002
517 NASAL POLYPS 1 0.0002
518 IMMUNODEFICIENCY 3 0.0002
519 APPLICATION SITE SWELLING 1 0.0002
520 CONDITION AGGRAVATED 61 0.0002
521 HYPOTONIA 2 0.0002
522 CORONARY ARTERY STENOSIS 1 0.0002
523 CORONARY ARTERIAL STENT INSERTION 1 0.0002
524 PATHOLOGICAL FRACTURE 1 0.0002
525 DRUG LEVEL DECREASED 2 0.0002
526 MUSCLE SPASMS 36 0.0002
527 PHLEBITIS 1 0.0002
528 INITIAL INSOMNIA 2 0.0002
529 PERIPHERAL VASCULAR DISORDER 1 0.0002
530 PERIORBITAL OEDEMA 1 0.0002
531 MALABSORPTION 1 0.0002
532 APLASTIC ANAEMIA 1 0.0002
533 BRAIN FOG 3 0.0002
534 WEIGHT FLUCTUATION 2 0.0002
535 POLYARTHRITIS 1 0.0002
536 INCONTINENCE 2 0.0002
537 RESPIRATORY TRACT CONGESTION 3 0.0002
538 SURGERY 11 0.0002
539 FOOD POISONING 1 0.0002
540 COMPRESSION FRACTURE 1 0.0002
541 HEREDITARY ANGIOEDEMA 2 0.0002
542 OVERWEIGHT 1 0.0002
543 ERYTHEMA 38 0.0002
544 BEHAVIOUR DISORDER 1 0.0002
545 ERYTHEMA OF EYELID 1 0.0002
546 RASH PRURITIC 10 0.0002
547 HYDROCEPHALUS 1 0.0002
548 MUSCULOSKELETAL STIFFNESS 16 0.0002
549 NONSPECIFIC REACTION 1 0.0002
550 GASTROINTESTINAL PAIN 2 0.0002
551 BLOOD UREA INCREASED 3 0.0002
552 ORAL PAIN 4 0.0002
553 ANGIOPATHY 1 0.0002
554 EYE INFECTION 2 0.0002
555 FLUID RETENTION 9 0.0002
556 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
557 CHOLECYSTITIS ACUTE 1 0.0002
558 SCAB 2 0.0002
559 CHOLECYSTECTOMY 2 0.0002
560 EXERCISE TOLERANCE DECREASED 1 0.0002
561 EYE IRRITATION 10 0.0002
562 HERPES VIRUS INFECTION 1 0.0002
563 ECZEMA 9 0.0002
564 VISUAL IMPAIRMENT 21 0.0002
565 BLOOD IRON DECREASED 2 0.0002
566 MACULAR DEGENERATION 2 0.0002
567 HYPERLIPIDAEMIA 2 0.0002
568 COMPLICATION OF DEVICE REMOVAL 3 0.0002
569 DECREASED APPETITE 38 0.0002
570 MUSCLE SPASTICITY 2 0.0002
571 NASOPHARYNGITIS 30 0.0002
572 PHARYNGITIS 2 0.0002
573 CYST 2 0.0002
574 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
575 APPLICATION SITE IRRITATION 2 0.0002
576 SWOLLEN TONGUE 5 0.0002
577 POISONING 2 0.0002
578 BLOOD SODIUM DECREASED 3 0.0002
579 DERMATITIS ALLERGIC 2 0.0002
580 INFUSION SITE SWELLING 1 0.0002
581 CHEST PAIN 29 0.0002
582 HEPATITIS 4 0.0002
583 EXPOSURE VIA SKIN CONTACT 4 0.0002
584 THERAPY INTERRUPTED 11 0.0002
585 ANGINA UNSTABLE 1 0.0002
586 DYSGRAPHIA 1 0.0002
587 PANCREATITIS 8 0.0002
588 CARDIAC FAILURE ACUTE 1 0.0001
589 PREGNANCY 3 0.0001
590 HAIR TEXTURE ABNORMAL 2 0.0001
591 POST-TRAUMATIC STRESS DISORDER 1 0.0001
592 BREAST MASS 1 0.0001
593 EYE PRURITUS 5 0.0001
594 PRODUCT ADMINISTRATION ERROR 3 0.0001
595 COLITIS ISCHAEMIC 1 0.0001
596 METASTASES TO LYMPH NODES 1 0.0001
597 FEEDING DISORDER 3 0.0001
598 HYPERTENSION 31 0.0001
599 BLOOD TESTOSTERONE DECREASED 1 0.0001
600 APPLICATION SITE RASH 2 0.0001
601 ONYCHOCLASIS 1 0.0001
602 ENCEPHALITIS 1 0.0001
603 HYPOMAGNESAEMIA 2 0.0001
604 HUNGER 2 0.0001
605 PRURITUS 55 0.0001
606 OFF LABEL USE 125 0.0001
607 APPLICATION SITE REACTION 1 0.0001
608 SKIN REACTION 2 0.0001
609 BLINDNESS UNILATERAL 2 0.0001
610 DUODENAL ULCER 1 0.0001
611 HAND FRACTURE 1 0.0001
612 ARTHRALGIA 58 0.0001
613 PANIC REACTION 1 0.0001
614 DERMATITIS BULLOUS 1 0.0001
615 FAECES SOFT 1 0.0001
616 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
617 MAJOR DEPRESSION 1 0.0001
618 ORAL DISORDER 1 0.0001
619 MEDICAL DEVICE COMPLICATION 1 0.0001
620 TOOTH DISORDER 3 0.0001
621 HYPERSENSITIVITY 25 0.0001
622 FEELING DRUNK 1 0.0001
623 EYE SWELLING 5 0.0001
624 SNEEZING 3 0.0001
625 ASTHENIA 50 0.0001
626 PAROSMIA 1 0.0001
627 APPLICATION SITE PRURITUS 3 0.0001
628 DRUG INEFFECTIVE 174 0.0001
629 INFECTION 19 0.0001
630 SUICIDAL IDEATION 12 0.0001
631 SKIN DISCOLOURATION 6 0.0001
632 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
633 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
634 PSORIASIS 17 0.0001
635 ANXIETY 37 0.0001
636 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
637 HAEMOLYSIS 1 0.0001
638 THERAPY PARTIAL RESPONDER 2 0.0001
639 MULTIPLE ALLERGIES 1 0.0001
640 OCULAR HYPERAEMIA 6 0.0001
641 FURUNCLE 1 0.0001
642 GINGIVAL PAIN 1 0.0001
643 GAIT DISTURBANCE 24 0.0001
644 ATRIAL FLUTTER 1 0.0001
645 ABORTION SPONTANEOUS 5 0.0001
646 ABDOMINAL DISTENSION 13 0.0001
647 DIZZINESS 62 0.0001
648 LOCALISED INFECTION 3 0.0001
649 PNEUMONIA 40 0.0001
650 UNDERDOSE 9 0.0001
651 OEDEMA PERIPHERAL 15 0.0001
652 INJECTION SITE URTICARIA 3 0.0001
653 HICCUPS 1 0.0001
654 HYPERAESTHESIA 1 0.0001
655 HAIR DISORDER 1 0.0001
656 PHOTOSENSITIVITY REACTION 2 0.0001
657 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
658 SKIN DISORDER 4 0.0001
659 ATRIAL SEPTAL DEFECT 1 0.0001
660 PRODUCT DOSE OMISSION ISSUE 35 0.0001
661 ABDOMINAL PAIN 27 0.0001
662 MYOPATHY 1 0.0001
663 BALANCE DISORDER 10 0.0001
664 MUSCLE STRAIN 1 0.0001
665 CARDIAC MURMUR 1 0.0001
666 THERAPEUTIC RESPONSE DECREASED 7 0.0001
667 VERTIGO 7 0.0001
668 METASTASES TO LIVER 2 0.0001
669 HEAD DISCOMFORT 2 0.0001
670 PAIN OF SKIN 3 0.0001
671 URINARY TRACT INFECTION 19 0.0001
672 DISTURBANCE IN ATTENTION 6 0.0001
673 HEAVY MENSTRUAL BLEEDING 1 0.0001
674 WEIGHT DECREASED 31 0.0001
675 PELVIC PAIN 2 0.0001
676 DIARRHOEA 71 0.0001
677 PANIC ATTACK 4 0.0001
678 INCREASED TENDENCY TO BRUISE 1 0.0001
679 PAIN IN EXTREMITY 32 0.0001
680 BREAST CANCER STAGE I 1 0.0001
681 CHEST DISCOMFORT 11 0.0001
682 FLANK PAIN 1 0.0001
683 PHOTOPHOBIA 2 0.0001
684 LACERATION 1 0.0001
685 ABORTION INDUCED 1 0.0001
686 BLOOD URINE PRESENT 2 0.0001
687 INSOMNIA 28 0.0001
688 DISEASE RECURRENCE 5 0.0001
689 FEELING JITTERY 2 0.0001
690 SLEEP APNOEA SYNDROME 2 0.0001
691 RASH ERYTHEMATOUS 5 0.0001
692 PYREXIA 36 0.0001
693 AFFECT LABILITY 1 0.0001
694 ATELECTASIS 1 0.0001
695 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
696 CHOKING 2 0.0001
697 PHARYNGEAL SWELLING 1 0.0001
698 ASCITES 3 0.0001
699 KIDNEY INFECTION 2 0.0001
700 EMBEDDED DEVICE 1 0.0001
701 BLOOD PRESSURE ABNORMAL 2 0.0001
702 COMPLICATION OF DEVICE INSERTION 2 0.0001
703 LACRIMATION INCREASED 3 0.0001
704 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
705 DRY THROAT 1 0.0001
706 EAR DISCOMFORT 1 0.0001
707 THERAPY CESSATION 5 0.0001
708 PRODUCT PREPARATION ERROR 2 0.0001
709 POOR VENOUS ACCESS 1 0.0001
710 HYPERBILIRUBINAEMIA 1 0.0001
711 EYE DISCHARGE 1 0.0001
712 POLLAKIURIA 4 0.0001
713 PETECHIAE 1 0.0001
714 DERMATITIS 2 0.0001
715 MOUTH ULCERATION 2 0.0001
716 VISION BLURRED 13 0.0001
717 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
718 BREAST PAIN 1 0.0001
719 IMPAIRED WORK ABILITY 2 0.0001
720 BREAST CANCER METASTATIC 1 0.0001
721 RHINORRHOEA 6 0.0001
722 DECREASED ACTIVITY 1 0.0001
723 MENSTRUATION DELAYED 1 0.0001
724 DEVICE DISLOCATION 4 0.0001
725 PRODUCT DISPENSING ERROR 2 0.0001
726 OESOPHAGITIS 1 0.0001
727 TREATMENT NONCOMPLIANCE 5 0.0001
728 EXPIRED PRODUCT ADMINISTERED 3 0.0001
729 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
730 EYE PAIN 5 0.0001
731 FLATULENCE 5 0.0001
732 INJECTION SITE REACTION 6 0.0001
733 PRODUCT SUBSTITUTION ISSUE 5 0.0001
734 MUSCLE TWITCHING 2 0.0001
735 CAESAREAN SECTION 1 0.0001
736 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
737 HEART RATE DECREASED 3 0.0001
738 NASAL CONGESTION 5 0.0001
739 LYMPHADENOPATHY 3 0.0001
740 DYSPHAGIA 8 0.0001
741 BACTERAEMIA 1 0.0001
742 HEPATITIS C 1 0.0001
743 CONSTIPATION 18 0.0001
744 NOCTURIA 1 0.0001
745 ACCIDENTAL OVERDOSE 3 0.0001
746 DYSURIA 3 0.0001
747 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
748 HAIR COLOUR CHANGES 1 0.0001
749 AGEUSIA 2 0.0001
750 INJECTION SITE DISCOLOURATION 1 0.0001
751 LEUKOPENIA 4 0.0001
752 COVID-19 14 0.0001
753 HALLUCINATION 6 0.0001
754 HOT FLUSH 6 0.0001
755 INTESTINAL OBSTRUCTION 3 0.0001
756 DYSPNOEA 45 0.0001
757 TACHYCARDIA 7 0.0001
758 INJECTION SITE IRRITATION 1 0.0001
759 DEVICE DEPLOYMENT ISSUE 1 0.0001
760 HYPOPHAGIA 2 0.0001
761 DRUG RESISTANCE 2 0.0001
762 ILLNESS 8 0.0001
763 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
764 PLATELET COUNT INCREASED 1 0.0001
765 HEADACHE 48 0.0001
766 GASTRITIS 2 0.0001
767 IMMUNE SYSTEM DISORDER 1 0.0001
768 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
769 THROAT TIGHTNESS 2 0.0001
770 PULMONARY EMBOLISM 7 0.0001
771 IMPAIRED GASTRIC EMPTYING 1 0.0001
772 BACK PAIN 17 0.0001
773 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
774 MALAISE 32 0.0001
775 PERIPHERAL COLDNESS 1 0.0001
776 ABNORMAL DREAMS 2 0.0001
777 ORAL DISCOMFORT 1 0.0001
778 FEELING COLD 2 0.0001
779 MASS 1 0.0001
780 CARPAL TUNNEL SYNDROME 1 0.0001
781 BLOOD TEST ABNORMAL 1 0.0001
782 HEART RATE INCREASED 7 0.0001
783 BRONCHOSPASM 1 0.0001
784 ANGINA PECTORIS 2 0.0001
785 FATIGUE 54 0.0001
786 PARAESTHESIA ORAL 1 0.0001
787 ANOSMIA 1 0.0001
788 HYPOKINESIA 1 0.0001
789 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
790 INTENTIONAL PRODUCT MISUSE 6 0.0001
791 PALPITATIONS 8 0.0001
792 ANGIOEDEMA 3 0.0001
793 BRONCHITIS 5 0.0001
794 URINARY INCONTINENCE 2 0.0001
795 DYSGEUSIA 5 0.0001
796 NAUSEA 53 0.0001
797 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
798 BONE LOSS 1 0.0001
799 CORONARY ARTERY DISEASE 2 0.0001
800 BLOOD COUNT ABNORMAL 1 0.0001
801 OSTEOPENIA 1 0.0001
802 BLOOD PRESSURE INCREASED 10 0.0001
803 TINNITUS 3 0.0001
804 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
805 HYPOKALAEMIA 3 0.0001
806 OROPHARYNGEAL PAIN 6 0.0001
807 INJECTION SITE ERYTHEMA 8 0.0001
808 DELUSION 1 0.0001
809 ACUTE MYELOID LEUKAEMIA 1 0.0001
810 MENINGIOMA 1 0.0001
811 ARRHYTHMIA 3 0.0001
812 MOOD SWINGS 2 0.0001
813 ABSCESS 1 0.0001
814 HYPOTHYROIDISM 2 0.0001
815 HIP FRACTURE 2 0.0001
816 HYPERHIDROSIS 8 0.0001
817 BLOOD POTASSIUM INCREASED 1 0.0001
818 METASTASES TO BONE 1 0.0001
819 EYE DISORDER 2 0.0001
820 FUNGAL INFECTION 2 0.0001
821 CELLULITIS 3 0.0001
822 FACE OEDEMA 1 0.0001
823 CANDIDA INFECTION 1 0.0001
824 FLUSHING 6 0.0001
825 METRORRHAGIA 1 0.0001
826 HOSPITALISATION 9 0.0001
827 GASTRIC DISORDER 2 0.0001
828 MUSCULOSKELETAL DISCOMFORT 1 0.0001
829 PARANOIA 1 0.0001
830 NIGHTMARE 2 0.0001
831 NEOPLASM PROGRESSION 2 0.0001
832 ORTHOSTATIC HYPOTENSION 1 0.0001
833 NERVOUSNESS 3 0.0001
834 RASH MACULAR 2 0.0001
835 DEVICE USE ISSUE 1 0.0001
836 PRODUCT STORAGE ERROR 5 0.0001
837 COUGH 16 0.0001
838 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
839 LYMPHOCYTE COUNT DECREASED 1 0.0001
840 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
841 ISCHAEMIC STROKE 1 0.0001
842 GALLBLADDER DISORDER 1 0.0001
843 GOUT 1 0.0001
844 INJECTION SITE PAIN 17 0.0001
845 GASTROENTERITIS VIRAL 1 0.0001
846 LEUKOCYTOSIS 1 0.0001
847 DEPENDENCE 3 0.0001
848 HAEMATOCHEZIA 3 0.0001
849 ANAPHYLACTIC REACTION 3 0.0001
850 TREMOR 9 0.0001
851 CONJUNCTIVITIS 1 0.0001
852 HEPATIC STEATOSIS 1 0.0001
853 BACTERIAL INFECTION 1 0.0001
854 EPISTAXIS 4 0.0001
855 HYPONATRAEMIA 3 0.0001
856 DYSPNOEA EXERTIONAL 2 0.0001
857 NEUROPATHY PERIPHERAL 5 0.0001
858 MUSCULOSKELETAL DISORDER 1 0.0001
859 ANAEMIA 10 0.0001
860 INJECTION SITE SWELLING 4 0.0001
861 POST PROCEDURAL COMPLICATION 1 0.0001
862 DYSTONIA 1 0.0001
863 DYSPHONIA 3 0.0001
864 BONE PAIN 3 0.0001
865 ARTHRITIS 4 0.0001
866 CYTOKINE RELEASE SYNDROME 1 0.0000
867 THROMBOSIS 4 0.0000
868 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
869 PLEURAL EFFUSION 3 0.0000
870 DYSKINESIA 2 0.0000
871 INJURY ASSOCIATED WITH DEVICE 1 0.0000
872 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
873 RHABDOMYOLYSIS 2 0.0000
874 SKIN EXFOLIATION 4 0.0000
875 MYALGIA 8 0.0000
876 EATING DISORDER 1 0.0000
877 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
878 MENTAL DISORDER 2 0.0000
879 BLOOD CREATININE INCREASED 3 0.0000
880 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
881 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
882 MELAENA 1 0.0000
883 BLOOD PRESSURE DECREASED 3 0.0000
884 INJECTION SITE PRURITUS 3 0.0000
885 CHROMATURIA 1 0.0000
886 DISEASE PROGRESSION 5 0.0000
887 FEELING ABNORMAL 10 0.0000
888 BLOOD PRESSURE FLUCTUATION 1 0.0000
889 MENTAL IMPAIRMENT 1 0.0000
890 NEURALGIA 1 0.0000
891 CEREBRAL INFARCTION 1 0.0000
892 AGITATION 3 0.0000
893 ABASIA 1 0.0000
894 EXTRAPYRAMIDAL DISORDER 1 0.0000
895 PNEUMONIA ASPIRATION 1 0.0000
896 SYNCOPE 4 0.0000
897 CHRONIC KIDNEY DISEASE 3 0.0000
898 HAEMATEMESIS 1 0.0000
899 FALL 13 0.0000
900 LOSS OF CONSCIOUSNESS 5 0.0000
901 ERECTILE DYSFUNCTION 1 0.0000
902 HAEMATOMA 1 0.0000
903 DIPLOPIA 1 0.0000
904 SPEECH DISORDER 2 0.0000
905 ANHEDONIA 1 0.0000
906 DEPRESSED MOOD 2 0.0000
907 INJECTION SITE BRUISING 3 0.0000
908 DEHYDRATION 5 0.0000
909 BREAST CANCER FEMALE 1 0.0000
910 DRUG EFFECT DECREASED 2 0.0000
911 BLOOD BILIRUBIN INCREASED 1 0.0000
912 LIMB INJURY 1 0.0000
913 PALLOR 1 0.0000
914 MOOD ALTERED 1 0.0000
915 INFLUENZA LIKE ILLNESS 3 0.0000
916 INFLUENZA 4 0.0000
917 SEPSIS 4 0.0000
918 INTENTIONAL DOSE OMISSION 1 0.0000
919 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
920 HERPES ZOSTER 2 0.0000
921 SOMNOLENCE 7 0.0000
922 NEEDLE ISSUE 1 0.0000
923 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
924 CATARACT 2 0.0000
925 BLOOD POTASSIUM DECREASED 1 0.0000
926 PREMATURE BABY 1 0.0000
927 HEPATIC FAILURE 1 0.0000
928 EMOTIONAL DISTRESS 4 0.0000
929 INJECTION SITE RASH 1 0.0000
930 LIMB DISCOMFORT 1 0.0000
931 FEMUR FRACTURE 1 0.0000
932 BREAST CANCER 3 0.0000
933 NERVOUS SYSTEM DISORDER 1 0.0000
934 BONE DENSITY DECREASED 1 0.0000
935 HEAD INJURY 1 0.0000
936 CYSTITIS 1 0.0000
937 MOVEMENT DISORDER 1 0.0000
938 ATRIAL FIBRILLATION 3 0.0000
939 PRODUCT DOSE OMISSION 2 0.0000
940 CHOLELITHIASIS 1 0.0000
941 OSTEONECROSIS 1 0.0000
942 NEOPLASM MALIGNANT 2 0.0000
943 HAEMATURIA 1 0.0000
944 CEREBRAL HAEMORRHAGE 1 0.0000
945 CRYING 1 0.0000
946 COLITIS 1 0.0000
947 SEIZURE 3 0.0000
948 PROSTATE CANCER 2 0.0000
949 DEVICE BREAKAGE 1 0.0000
950 NEUTROPHIL COUNT DECREASED 1 0.0000
951 HYPOACUSIS 1 0.0000
952 NO ADVERSE EVENT 4 0.0000
953 NEUTROPENIA 3 0.0000
954 COGNITIVE DISORDER 1 0.0000
955 MULTIPLE SCLEROSIS 1 0.0000
956 BLOOD GLUCOSE DECREASED 1 0.0000
957 AGGRESSION 1 0.0000
958 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
959 HAEMORRHAGE 2 0.0000
960 BRADYCARDIA 1 0.0000
961 PLATELET COUNT DECREASED 2 0.0000
962 OVERDOSE 4 0.0000
963 THROMBOCYTOPENIA 2 0.0000
964 INCORRECT DOSE ADMINISTERED 4 0.0000
965 CONVULSION 1 0.0000
966 LETHARGY 1 0.0000
967 MYOCARDIAL INFARCTION 3 0.0000
968 CHILLS 2 0.0000
969 IRRITABILITY 1 0.0000
970 DEEP VEIN THROMBOSIS 1 0.0000
971 RENAL FAILURE 2 0.0000
972 DIABETES MELLITUS 1 0.0000
973 DRUG INTERACTION 2 0.0000
974 INJECTION SITE HAEMORRHAGE 1 0.0000
975 CARDIAC FAILURE 1 0.0000
976 COMPLETED SUICIDE 1 0.0000
977 CEREBROVASCULAR ACCIDENT 2 0.0000
978 DEVICE ISSUE 1 0.0000
979 BLOOD GLUCOSE INCREASED 2 0.0000
980 HYPOTENSION 2 0.0000
981 HAEMOGLOBIN DECREASED 1 0.0000
982 DEATH 8 0.0000
983 ACUTE KIDNEY INJURY 1 0.0000
984 DRUG DEPENDENCE 1 0.0000
985 DRUG DOSE OMISSION 1 0.0000